Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sorrento Therpt 4955 DIRECTORS PLACE SAN DIEGO CA 92121 USA

P: 858-203-4100 F: 858-203-4028

Description:

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 2,884,430
Shares Outstanding, K 262,938
Annual Sales, $ 31,430 K
Annual Net Income, $ -292,070 K
Last Quarter Sales, $ 11,750 K
Last Quarter Net Income, $ -84,020 K
60-Month Beta 2.35
% of Insider Shareholders 3.40%
% of Institutional Shareholders 29.57%
Float, K 253,998
% Float 96.60%

Growth:

1-Year Return 392.44%
3-Year Return 52.36%
5-Year Return 78.37%
5-Year Revenue Growth 720.63%
5-Year Earnings Growth -63.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/01/21
Earnings Per Share ttm -1.22
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year 21.43%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-25 on 08/01/13

SRNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.99
Price/Earnings to Growth N/A
Return-on-Equity % -239.75%
Return-on-Assets % -45.34%
Profit Margin % -929.27
Net Margin % N/A
Debt/Equity 1.03
Price/Sales 72.37
Price/Cash Flow N/A
Price/Book 23.95
Book Value/Share 0.55
Interest Coverage -8.95
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar